Mesa Laboratories, Inc.
MLAB · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2027 Q1 | August 5, 2026 | — | 60.87M | — | 2.63 | — |
| 2026 Q4 | May 27, 2026 | 63.72M | 65.21M | 2.76 | 2.45 | -14.48% |
| 2026 Q3 | February 3, 2026 | 65.13M | 63.23M | 2.46 | 2.41 | +8.73% |
| 2026 Q2 | November 6, 2025 | 60.74M | 61.03M | 1.22 | 1.56 | +1.52% |
| 2026 Q1 | August 5, 2025 | 59.54M | 60.40M | 1.62 | 2.46 | -24.92% |
| 2025 Q4 | May 28, 2025 | 62.14M | 61.90M | 2.23 | 2.75 | — |
| 2025 Q3 | February 4, 2025 | 62.84M | 61.53M | 2.07 | 2.45 | +2.49% |
| 2025 Q2 | November 7, 2024 | 57.83M | 57.88M | 1.81 | 2.48 | +1.99% |
| 2025 Q1 | August 5, 2024 | 58.17M | 55.74M | 2.29 | 2.33 | — |
| 2024 Q4 | June 5, 2024 | 58.90M | 55.27M | 2.25 | -0.11 | -13.41% |
| 2024 Q3 | February 5, 2024 | 53.47M | 54.00M | 1.46 | 2.04 | +5.64% |
| 2024 Q2 | November 6, 2023 | 53.17M | 54.65M | 1.32 | 1.65 | -1.41% |
| 2024 Q1 | August 3, 2023 | 50.65M | 51.85M | 1.22 | 1.67 | +5.23% |
| 2023 Q4 | May 25, 2023 | 55.59M | 57.40M | 1.46 | 1.98 | -1.97% |
| 2023 Q3 | February 5, 2023 | 54.29M | 57.04M | 1.96 | 2.10 | -9.08% |
| 2023 Q2 | November 2, 2022 | 58.75M | 53.24M | 2.07 | 1.39 | +9.86% |